You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.
-
A new radiopharmaceutical for the treatment of metastatic bone cancer
SBC: IsoTherapeutics Group LLC Topic: NCIDESCRIPTION provided by applicant There are roughly new cases of metastatic cancer to the skeleton in the U S each year andquot Bone seekingandquot radiopharmaceuticals are used for bone pain palliation and have shown promise for treating bone metastases They typically combine a radioactive metal such as samarium with a chelant The chelant part of the molecule is taken up by gr ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Biomarker Quantitation by NP-MS Tissue Imaging.
SBC: Ionwerks, Inc. Topic: NIDADESCRIPTION provided by applicant MALDI tissue imaging when enabled by Nanoparticulate NP Matrix implantation is maturing into a useful preclinical tool for biomarker and drug discovery in our laboratory and at NIDA IRP Quantitatively reproducible images from serial coronal sections suggest that relative quantitation is now possible in rodent models of disease and injury Nanoparticulate ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Long-Acting G-CSF Analog for Treating ARS
SBC: BOLDER BIOTECHNOLOGY INC Topic: NIAIDDESCRIPTION provided by applicant Development of radiological nuclear medical countermeasures to treat Acute Radiation Syndrome ARS is a high priority research area for NIAID Bone marrow is one of the most sensitive tissues to radiation damage and impaired hematopoiesis is one of the first clinical signs of excessive radiation exposure often resulting i death Granulocyte colony stimulating ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Development of Inhaled Vancomycin for Treatment of MRSA Infections in CF
SBC: SAVARA INC. Topic: NHLBIDESCRIPTION provided by applicant Persistent respiratory methicillin resistant Staphylococcus aureus MRSA infections have become increasingly common in cystic fibrosis CF patients with a prevalence of almost in CF patients in the US This is concerning as MRSA positivity is associated with a faster decline of lung function and a years shorter median life expectancy compared to CF p ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Carisbamate Treatment for Alcohol Dependence
SBC: Medication Discovery Texas, Inc Topic: NIAAADESCRIPTION (provided by applicant): Though not specifically FDA-approved for this indication, topiramate is among the most effective medication treatments for alcohol dependence. Topiramate is rarely used to treat alcohol dependence, however, because it has prominent side effects including somnolence, dizziness, and cognitive disturbances that require gradual dose titration. Many patients stop ta ...
STTR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Resonant-Photonic-Device-Enhanced SERS Substrate with Pinpointed Plasmonic-Active
SBC: Omega Optics, Inc. Topic: NIEHSDESCRIPTION (provided by applicant): The use of Surface Enhanced Raman Scattering (SERS) for biomolecule detection has been restricted due to the great difficulty of fabricating ultrasensitive and reproducible surface-plasmonic-resonance (SPR) substrates.Therefore, detecting extremely small amount of biomolecules for clinical application is significantly limited. In this STTR Phase II research, w ...
STTR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Alafair Biosciences develops cross-linked polysaccharide hydrogel films to addres
SBC: ALAFAIR BIOSCIENCES, INC. Topic: NIGMSDESCRIPTION (provided by applicant): The goal of this STTR project is to develop a pre-formed, naturally-based hydrogel postoperative adhesion barrier with improved handling characteristics, laparoscopic deliverability, and consistent efficacy. Our technology is based on a novel, patented process that imparts exceptional elasticity and toughness on normally brittle, weak materials. Postoperative a ...
STTR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
IYG-Family: Beyond the talk to effective pregnancy, STI, and HIV prevention
SBC: Radiant Creative Group, LLC Topic: NICHDDESCRIPTION (provided by applicant): The goal of this 3 year Fast-Track STTR is to develop and evaluate a home-based intervention ('it's Your Game- Family') to provide age-appropriate sexual health life skills education and training for children (11-14 years) and to enhance parents' skills and self-confidence in support of this training. IYG-Family (IYG-F) will be an on-line g ...
STTR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Development of a Biochemical Diagnosis for Creutzfeldt-Jakob disease
SBC: Amprion, Inc. Topic: NINDSDESCRIPTION (provided by applicant): Human prion diseases are infectious and invariably fatal forms of neurodegenerative diseases, including sporadic Creutzfeldt-Jakob disease (sCJD), the most common form, and variant CJD (vCJD) which is associated to consumption of cattle meat infected by bovine spongiform encephalopathy. Currently there is not sensitive, objective and non-invasive biochemical di ...
STTR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Long-Acting G-CSF Analog for Treating ARS
SBC: BOLDER BIOTECHNOLOGY INC Topic: NIAIDDESCRIPTION (provided by applicant): Development of radiological/nuclear medical countermeasures to treat Acute Radiation Syndrome (ARS) is a high priority research area for NIAID. Bone marrow is one of the most sensitive tissues to radiation damage and impaired hematopoiesis is one of the first clinical signs of excessive radiation exposure, often resulting i death. Granulocyte colony-stimulating ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health